FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...